Latest news with #Action
Metro
12 hours ago
- Sport
- Metro
World Matchplay Darts 2025 schedule, time, TV channel and odds
The 2025 World Matchplay gets underway at the Winter Gardens in Blackpool on Saturday night, with the defending champion in action. Luke Humphries lifted the Phil Taylor Trophy last year, beating Michael van Gerwen 18-15 in the final. The world number one is a leading contender to claim the title again, alongside the likes of world champion Luke Littler and the bang in form Gerwyn Price. The World Matchplay is notoriously difficult to win on more than one occasion, though, with only three players ever managing multiple Matchplay titles. The Power dominated the event for so long, winning it 16 times, with only Van Gerwen (three) and Rod Harrington (two) boasting more than one title.. Humphries could join that very small club this year, as could James Wade, Gary Anderson, Peter Wright, Dimitri van den Bergh, Rob Cross and NAthan Aspinall. Littler is favourite, though, despite never winning a match in the tournament before as he lost in the opening round to MVG on debut 12 months ago. The tournament runs from Saturday July 19 to the final on Sunday July 27. Sky Sports will be showing the tournament, on Sky Sports Main Event and Action. Streaming is available on Sky Go and for non-Sky Sports subscribers through Now TV. Saturday July 19 7pmJames Wade v Joe CullenDanny Noppert v Cameron MenziesLuke Humphries v Gian van Veen Nathan Aspinall v Wessel Nijman Sunday July 20 1pmDamon Heta v Andrew GildingRob Cross v Dirk van DuijvenbodePeter Wright v Jermaine Wattimena Dave Chisnall v Mike De Decker 7pmGary Anderson v Luke WoodhouseJonny Clayton v Martin SchindlerLuke Littler v Ryan Searle Stephen Bunting v Ryan Joyce Monday July 21 7pmChris Dobey v Ricardo PietreczkoGerwyn Price v Daryl GurneyMichael van Gerwen v Raymond van Barneveld Ross Smith v Josh Rock Tuesday July 22 Second Round – 7pmHumphries/Van Veen v Noppert/MenziesAspinall/Nijman v Wade/CullenBunting/Joyce v Anderson/Woodhouse Clayton/Schindler v Chisnall/De Decker Wednesday July 23 Second Round x4 – 7pmLittler/Searle v Wright/WattimenaHeta/Gilding v Cross/Van DuijvenbodeVan Gerwen/Van Barneveld v Smith/Rock Dobey/Pietreczko v Price/Gurney Thursday July 24 Quarter-Finals – 8pm Friday July 25 Quarter-Finals – 8pm Saturday July 26 Semi-Finals – 8pm Sunday July 27 Final – 8pm Speaking ahead of his title defence, Cool Hand said: 'This would be a very, very special title to retain. 'The World Matchplay is one of those tournaments I wanted to win more than anything, so it will always hold a special place in my heart. 'I think the venue is so iconic, the fans all love their darts and they just create a brilliant atmosphere. 'Some of the greatest highlights in darting history have been created at the World Matchplay, and I think that's why it's so prestigious.' Luke Littler 2/1Luke Humphries 7/2Gerwyn Price 8/1Josh Rock 14/1Michael van Gerwen 18/1Gary Anderson 18/1Stephen Bunting 18/1Nathan Aspinall 22/1Jonny Clayton 25/1Gian van Veen 28/1Chris Dobey 33/1Rob Cross 50/1Mike de Decker 50/1Wessel Nijman 50/1Ross Smith 50/1Damon Heta 50/1Dirk van Duijvenbode 50/1Ryan Searle 66/1Martin Schindler 66/1James Wade 66/1Dave Chisnall 80/1Danny Noppert 80/1Peter Wright 100/1Cameron Menzies 100/1Jermaine Wattimena 100/1Daryl Gurney 100/1Joe Cullen 125/1Ryan Joyce 150/1Andrew Gilding 150/1Raymond van Barneveld 150/1Luke Woodhouse 200/1 Ricardo Pietreczko 200/1 Odds courtesy of Betfred Winner £200,000Runner-up £100,000Semi-finalists £50,000Quarter-finalists £30,000Second round £15,000 First round £10,000 MORE: World Matchplay Darts draw sees legends collide in Blackpool MORE: Luke Humphries fires back at criticism of Luke Littler partnership
Irish Daily Mirror
a day ago
- Sport
- Irish Daily Mirror
Time and TV channel for the Lions v Australia first test today
It's time for the serious action for the British and Irish Lions as they take on Australia in the first of three tests. Andy Farrell's squad have won all five games in the build-up to the opener against Joe Schmidt's side following their 48-0 victory over an AUNZ Invitational XV in Adelaide last weekend. It's the first time the sides have met since 2013 with three test matches in store. The Lions will be hoping they can pick up another series win against an Australia side starting to get some form back. After a disappointing 2024 Rugby Championship they bounced backed with impressive autumn victories over England and Wales before ending their European campaign with defeats by Scotland and Ireland. It's all set up for an intriguing first meeting between the teams. Here is how you can watch the game: Where is the game on? Australia v British & Irish Lions will take place on Saturday 19th July, at the Suncorp Stadium in Brisbane. What time is kick-off? The match kicks off at 11am Irish time on Saturday You can watch the game live on Sky Sports Main Event and Action from 10am. Is there a live stream? Sky Sports customers can live stream the game via the Sky Go app on a variety of devices. Now TV are streaming the game. Betting odds Australia 4/1 British and Irish Lions 1/6 Draw 22/1 Referee Referee: Ben O'Keeffe(New Zealand) Team News British and Irish Lions: Keenan; Freeman, Jones, Tuipulotu, Lowe; Russell, Gibson-Park; Genge, Sheehan, Furlong; Itoje (c), McCarthy; Beirne, Curry, Conan Replacements: Kelleher, Porter, Stuart, Chessum, Earl, Mitchell, M Smith, Aki Australia: Wright; Jorgensen, Suaalii, Ikitau, Potter; Lynagh, Gordon; Alaalatoa, Faessler, Slipper; Frost, Williams; Champion de Crespigny, McReight, Wilson (c) Replacements: Pollard, Bell, Robertson, Hooper, Tizzano, McDermott, Donaldson, Kellaway
Arab News
2 days ago
- Entertainment
- Arab News
Four of 2025's top video games so far
'Indiana Jones and the Great Circle' There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. 'Split Fiction' There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. 'Mario Kart World' There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. 'Clair Obscur:Expedition 33' There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section. There will be roughly this much copy in this section.
&w=3840&q=100)
Business Standard
4 days ago
- Business
- Business Standard
Why did Shilpa Medicare share jump 5% in trade today? top details here
Shilpa Medicare share price: Pharmaceutical company Shilpa Medicare share price was in demand on Wednesday, July 16, 2025, with the scrip rising up to 4.99 per cent to hit an intraday high of ₹939.10 per share. Around 1:30 PM, Shilpa Medicare share price was trading 4.93 per cent higher at ₹938.50. By comparison, BSE Sensex was trading 0.08 per cent lower at 82,640.01 levels. CATCH STOCK MARKET LIVE UPDATES TODAY Why did Shilpa Medicare share price rise in trade today? Shilpa Medicare share price gained in trade after the company announced a positive regulatory update from the US health regulator, United States Food and Drug Administration (USFDA). The pharma firm said its Unit VI at Dabaspet, Bengaluru received an Establishment Inspection Report (EIR) with a 'Voluntary Action Indicated' (VAI) classification from the USFDA. The EIR followed a Good Manufacturing Practices (GMP) inspection conducted between October 24-30, 2024. In an exchange filing, Shilpa Medicare said, 'This is to inform you that Shilpa Medicare Limited, Unit VI, Dabaspet, Bengaluru, Karnataka, India has received EIR with VAI (Voluntary Action Indicated) classification, from USFDA, for the GMP inspection which was conducted from October 24 – 30, 2024.' The unit is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms including Oral Dissolving Films and Transdermal Systems. Meanwhile, the unit already holds approvals from key global regulators, including EMA (Europe), MHRA (UK), SFDA (Saudi Arabia), and TGA (Australia). It currently supplies oral film products to the US and other markets, while filings for transdermal products have been made in Europe. Shilpa Medicare Q4 results Shilpa Medicare reported a mixed set of numbers in Q4FY25. While revenue from operations grew 13.3 per cent year-on-year (Y-o-Y) to ₹330.80 crore and earnings before interest, tax, depreciation and amortisation (Ebitda) rose 15 per cent to ₹84 crore, net profit (PAT) declined 40.8 per cent to ₹14.51 crore. About Shilpa Medicare Shilpa Medicare Limited is a global pharmaceutical company with a strong presence in regulated markets such as the USA, Europe, and Japan. The company specialises in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage formulations, with a particular focus on oncology. Its product range includes tablets, capsules, injectables, and transdermal patches, all manufactured to meet international quality standards. Additionally, Shilpa Medicare provides end-to-end Contract Development and Manufacturing Organisation (CDMO) services, catering to a wide spectrum of pharmaceutical needs. Beyond its core offerings, the company is actively investing in research and development, focusing on novel drug delivery systems and expanding into emerging therapy areas, including biotech products. The market capitalisation of Shilpa Medicare is ₹9,177.68 crore, according to BSE. The company falls under the BSE SmallCap category.
Business Standard
4 days ago
- Business
- Business Standard
Shilpa Medicare gains as unit VI gets USFDA EIR with VAI classification
Shilpa Medicare added 2.94% to Rs 920.70 after the company announced that its Unit VI facility in Dabaspet, Bengaluru, Karnataka, has received EIR with VAI (Voluntary Action Indicated) classification from USFDA, for the GMP inspection. The good manufacturing practice (GMP) inspection was conducted from 24 October 2024 to 30 October 2024. This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms - oral dissolving films and transdermal systems. The Unit is already approved by EMA, Europe; MHRA, UK; SFDA, Saudi and TGA, Australia. This Unit is currently supplying Oral Film products to US and other markets. Transdermal products have been filed in the European market. Shilpa Medicare is a manufacturer of API, formulation, and development services. Shilpa Medicare (SML) started its operations as an API manufacturer way back in 1987 at Raichur, Karnataka, India. The company's consolidated net profit fell 40.77% to Rs 14.51 crore, while revenue from operations rose 13.40% to Rs 330.80 crore in Q4 FY25 over Q4 FY24.
